AXA/2025/FY/Earnings presentation: Difference between revisions

Content deleted Content added
PlumBot: publish from draft
PlumBot: publish from draft
Line 19:
=== Full Year 2025 earnings presentation ===
 
* AXA '''PresentationFull dateYear 2025''' earnings presentation delivered on February 26, 2026 <sup>p. 1</sup>.
* '''Company''' AXA <sup>p. 1</sup>
 
=== Important legal information and cautionary statements concerning forward-looking statements and the use of non-GAAP financial measures ===
 
* '''Forward-looking statements''' include predictions of or indicate future events, trends, plans, expectations, or objectives <sup>p. 2</sup>.
** Statements regarding expected '''Underlyingunderlying EPSearnings per share''' (UEPS) growth guidance for 2026 isare forward-looking statements providedto asprovide one-off guidance in the context of the last year of the Group's current strategic plan <sup>p. 2</sup>.
** '''RiskReaders factors'''should arerefer described into Part 5 "Risk Factors and Risk Management" of AXA's Universal Registration Document for the year ended December 31, 2024 for a description of important factors, risks, and uncertainties <sup>p. 2</sup>.
* '''AlternativeNon-GAAP performancefinancial measures''' or alternative performance measures (APMs) are used by managementManagement includeto underlyinganalyze earnings,operating UEPStrends, underlyingfinancial return on equity, combined ratioperformance, and debtfinancial gearingposition <sup>p. 2</sup>.
** APMs include "underlying earnings", UEPS ("underlying earnings per share"), "underlying return on equity", "combined ratio", and "debt gearing" <sup>p. 2</sup>.
* '''Financial statements''' for the year ended December 31, 2025 were examined by the Board of Directors on February 25, 2026, and are subject to completion of audit procedures <sup>p. 2</sup>.
** Reconciliations of APMs to the most closely related IFRS line items are provided in AXA's Activity Report as of December 31, 2025 <sup>p. 2</sup>.
* '''Financial statements''' for the year ended December 31, 2025 were examined by the Board of Directors on February 25, 2026, and are subject to completion of an audit procedure by AXA's statutory auditors <sup>p. 2</sup>.
 
=== Table of contents ===
 
* '''FY25 Highlights''' presented by Thomas Buberl, Group CEO <sup>p. 304</sup>
* '''FY25 Business Performance''' presented by Guillaume Borie, Global Head of Finance, Strategy, Underwriting, Risk, and Technology <sup>p. 309</sup>
* '''FY25 Financial Performance''' presented by Alban de Mailly Nesle, Group CFO <sup>p. 313</sup>
 
== FY25 Highlights ==
 
* '''SessionSection presenterpresentation''' titled "FY25 Highlights" presented by Thomas Buberl, Group CEO <sup>p. 4</sup>.
 
=== Full Year 2025 | Excellent performance ===
Line 46 ⟶ 47:
|+ Key financial highlights, FY25 <sup>p. 5</sup>
! style="text-align:left" | Metric
! class="col-ms" style="text-align:right" | Value
|-
| style="text-align:left" | Revenues
| class="col-ms" style="text-align:right" | +6% vs. FY24
|-
| style="text-align:left" | Underlying EPS
| class="col-ms" style="text-align:right" | +8% vs. FY24
|-
| style="text-align:left" | Return on equity (ROE)
| class="col-ms" style="text-align:right" | 16%
|-
| style="text-align:left" | Solvency II ratio
| class="col-ms" style="text-align:right" | 224%
|-
| style="text-align:left" | Shareholder value
| class="col-m" style="text-align:right" | +8% DPS growth and EUR 1.25bn annual share buyback
|-
| style="text-align:left" | EarningsShareholder guidancevalue delivery
| class="col-ms" style="text-align:right" | Confident+8% to deliver underlying EPSDPS growth atand the upper end of 6%-8%EUR target1.25bn rangeannual forshare 2026buyback
|}
</div>
* Dividend proposed by AXA's Board of Directors on February 25, 2026, subject to approval by the Shareholders' Annual General Meeting on April 30, 2026.
* Share buyback approved by AXA's Board of Directors on February 25, 2026, expected to commence as soon as reasonably practicable., subject to market conditions
* Future outlook indicates confidence to deliver underlying EPS growth at the upper end of the 6%-8% target range for 2026
 
=== Executing the plan on growth, margin and efficiency ===
Line 74 ⟶ 73:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Underlying earnings (constant FX), FY24 vs FY25 <sup>p. 6</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change (LFLconstant FX)
! class="col-s" style="text-align:right" | Change (excluding AXA IM)
|-
Line 88 ⟶ 87:
|}
</div>
* Top line growth +6% LFL, well balanced across lines: P&C +5%, Life +9%, Health +5%.
* Record profitability driven by further margin expansion in P&C and L&H, alongside improvement in efficiency.
* Scaling the business through continued investments in growth and technology.
* Earnings growth deliveredremains consistentlyconsistent while enhancing reserve prudence.
 
=== Diversified franchise, well positioned in an attractive industry ===
Line 97 ⟶ 96:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Business mix (by FY25 gross written premium split excluding AXA IM and holdings) <sup>p. 7</sup>
! style="text-align:left" | Segment
! class="col-s" style="text-align:right" | Share
Line 118 ⟶ 117:
</div>
 
* '''Secular trends''' fuelingfuel demand across businesses:, driven by protection gaps and emerging corporate risks alongside demographics driving demand for private retirement and healthcare.
* '''Our right to win''' is supported by four strategic pillars:
** Protection gaps and emerging corporate risks driving SME & Mid-market and Large & Specialty <sup>p. 7</sup>
** Leading brand & high customer NPS
** Demographics driving demand for private retirement and healthcare driving Life and Health <sup>p. 7</sup>
** Strong and diversified distribution
* '''Our right to win''' supported by four strategic pillars:
** Technical expertise to price & underwrite risks
** Leading brand & high customer NPS <sup>p. 7</sup>
** Scale offering cost advantage
** Strong and diversified distribution <sup>p. 7</sup>
** Technical expertise to price & underwriting risks <sup>p. 7</sup>
** Scale offering cost advantage <sup>p. 7</sup>
 
=== Laying the foundation for the next plan ===
 
* '''Strategic pillars''' established to lay the foundation for the next plan <sup>p. 8</sup>:
** '''Clear tech and AI roadmap''' <sup>p. 8</sup>
** '''Driving efficiency''' <sup>p. 8</sup>
** '''Enhancing capital allocation''' discipline <sup>p. 8</sup>
** '''Building resilience''' <sup>p. 8</sup>
* '''Earnings growth''' sustainabilityoutlook supported by strong confidence in sustaining performance <sup>p. 8</sup>.
 
== FY25 Business Performance ==
=== Section divider ===
 
* '''Section 2''': FY25 Business Performance''', presented by Guillaume Borie, Global Head of Finance, Strategy, Underwriting, Risk, and Technology <sup>p. 9</sup>.
 
== FY25 Business Performance ==
 
=== Strong delivery across our businesses ===
Line 146 ⟶ 141:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Key financial metrics by region <sup>p. 10</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | % of total GWP
! class="col-s" style="text-align:right" | GWPGross written premiums
! class="col-s" style="text-align:right" | GWPGross changewritten premiums LFL change
! class="col-s" style="text-align:right" | Underlying earnings
! class="col-s" style="text-align:right" | Underlying earnings change LFL change
|-
| style="text-align:left" | France
Line 182 ⟶ 178:
|}
</div>
 
* ''Note: Change for Gross written premiums is at constant scope and FX, and for underlying earnings at constant FX. FY25 gross written premiums exclude AXA IM, Holdings, AXA Assistance, and AXA Liabilities Managers <sup>p. 10</sup>.''
 
=== P&C | Strong margins, confidence in sustaining growth ===
Line 188 ⟶ 186:
{| class="wikitable fintable"
|+ GWP mix <sup>p. 11</sup>
! style="text-align:left" | EUR billionSegment
! class="col-s" style="text-align:right" | GWP
|-
Line 198 ⟶ 196:
|-
| style="text-align:left" | AXA XL (Large & Specialty)
| style="text-align:right" | 2.6bn
|-
| style="text-align:left; font-weight:bold" | Total
| style="text-align:right; font-weight:bold" | 58
|}
</div>
 
* '''Underlying earnings''' +9% LFL to EUR 5.9bn.
* AXA XL includes AXA XL Re premiums of EUR 2.6bn <sup>p. 11</sup>
* '''GWP mix''': Total GWP EUR 58bn, split across Retail, SME & Mid-market, and AXA XL (Large & Specialty).
* '''Underlying earnings''' +9% LFL to EUR 5.9bn (reported change FY25 vs. FY24 at constant FX) <sup>p. 11</sup>
* '''Retail and SME & Mid-market strategy''' strategic outlook:
** '''2025''': Growing volumes while expanding margins <sup>p. 11</sup>
** '''Beyond 2025''': Investing to improve customer retention &and expanding distribution footprint <sup>p. 11</sup>
* '''AXA XL (Large & Specialty) strategy''' strategic outlook:
** '''2025''': Profitable growth with stable margins <sup>p. 11</sup>
** '''Beyond 2025''': Capitalizing on attractive growth opportunities and continued cycle management <sup>p. 11</sup>
* '''Strategic enablers''':
** Continued progress on efficiency <sup>p. 11</sup>
** Higher investment income <sup>p. 11</sup>
** Data & AI to further enhance customer experience &and technical excellence <sup>p. 11</sup>
 
=== L&H | Good momentum, well positioned to capture growth opportunities ===
Line 222 ⟶ 217:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ GWP mix byand Long-term andUnderlying Short-termearnings <sup>p. 12</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | GWPValue
|-
| style="text-align:left; font-weight:bold" | TotalGWP total
| style="text-align:right; font-weight:bold" | 57
|-
| style="text-align:left" | Underlying earnings
| style="text-align:right" | 3.5
|-
| style="text-align:left" | Underlying earnings LFL change
| style="text-align:right" | +7%
|-
| style="text-align:left" | Long-term business
| style="text-align:right" | —
|-
| style="text-align:left" | Short-term business
| style="text-align:right" | —
|}
</div>
* '''Long-term business''' strategic priorities:
* '''Underlying earnings''' +7% LFL to EUR 3.5bn (reported change FY25 vs. FY24 at constant FX) <sup>p. 12</sup>
* '''Long-term business''' strategic outlook:
** '''2025''': Accelerating net flows in Savings at attractive margins <sup>p. 12</sup>
** '''Beyond 2025''': Capturing savings & retirement opportunity, sourcing best asset management products for our customers <sup>p. 12</sup>
* '''Short-term business''' strategic outlookpriorities:
** '''2025''': Growing technical results while absorbing Mexico VAT impact <sup>p. 12</sup>
** '''Beyond 2025''': Capitalizing on demand for health & protection while further improving our margins <sup>p. 12</sup>
Line 248:
** Leveraging AI to reduce claims leakage & improve customer outcomes in Health <sup>p. 12</sup>
 
=== FY25 Financial Performance ===
 
* '''Section divider3''': slideFY25 presentedFinancial by Alban de Mailly Nesle, Group CFOPerformance <sup>p. 13</sup>
* '''Presenter''': Alban de Mailly Nesle, Group CFO <sup>p. 13</sup>
 
=== P&C | Continued disciplined growth ===
Line 256 ⟶ 257:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ GWP & Otherother Revenuesrevenues by linesegment, FY24 vs FY25 <sup>p. 14</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | LFL Changechange
! class="col-s" style="text-align:right" | o/w pricing
! class="col-s" style="text-align:right" | o/w volume
Line 293 ⟶ 294:
|}
</div>
* '''Commercial lines''':
* Continued pricing momentum and volume growth in Mid-market and SME <sup>p. 14</sup>
** Continued pricing momentum and volume growth in Mid-market and SME <sup>p. 14</sup>
* Growing in lines of business with attractive margins while remaining focused on retention at AXA XL Insurance <sup>p. 14</sup>
** Growing in lines of business with attractive margins while remaining focused on retention at AXA XL Insurance <sup>p. 14</sup>
* Growth supported by alternative capital <sup>p. 14</sup>
* '''AXA XL Reinsurance''':
* Favorable pricing trends and strong growth in net new contracts (+1.7m in FY25) <sup>p. 14</sup>
** Growth supported by alternative capital <sup>p. 14</sup>
* '''Retail lines''':
** Favorable pricing trends and strong growth in net new contracts (+1.7m in FY25) <sup>p. 14</sup>
 
=== P&C | Delivering further margin expansion while enhancing reserve prudence ===
Line 302 ⟶ 306:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Combined ratio components, FY24 vs FY25 <sup>p. 15</sup>
! style="text-align:left" | %
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left" | Combined ratio
| style="text-align:right" | 91.0
| style="text-align:right" | 90.6
|-
| style="text-align:left" | Undiscounted CY loss ratio (ex Nat Cat)
Line 330:
| style="text-align:right" | -3.6
| style="text-align:right" | -3.5
|-
| style="text-align:left" | Combined ratio
| style="text-align:right" | 91.0
| style="text-align:right" | 90.6
|}
</div>
* '''Undiscounted CY loss ratio''' (ex Nat Cat) improved from:
* Better undiscounted current year loss ratio excluding Nat Cat from margin expansion in Commercial lines SME & mid-market business and Personal lines reflecting favorable pricing environment <sup>p. 15</sup>
** StableMargin AXAexpansion XLin InsuranceCommercial marginslines atSME attractive& levelsmid-market business and Personal lines reflecting disciplineda favorable cyclepricing managementenvironment <sup>p. 15</sup>
** Stable AXA XL Insurance margins at attractive levels reflecting disciplined cycle management <sup>p. 15</sup>
* Improvement in expense ratio reflecting the impact of efficiency measures, while continuing to invest in growth initiatives and technology <sup>p. 15</sup>
* '''Expense ratio''' improved reflecting the impact of efficiency measures, while continuing to invest in growth initiatives and technology <sup>p. 15</sup>
* Nat Cat charges below normalized load <sup>p. 15</sup>
* Lower'''Nat relianceCat oncharges''' priorbelow yearnormalized reserve developmentload <sup>p. 15</sup>
* Taking'''Prior year reserve development''' shows lower reliance, taking advantage of a good year to enhance reserve prudence <sup>p. 15</sup>
 
=== P&C | Earnings growth from higher underwriting and financial result ===
Line 372 ⟶ 376:
|}
</div>
* '''Underlying earnings''' grew +9% at constant FX.
 
* '''Underwriting result''' improved from strong volume growth and improved all-year combined ratio while enhancing reserve prudence <sup>p. 16</sup>.
* '''Investment income''' increased reflecting higher volumes and better reinvestment yields on fixed income assets <sup>p. 16</sup>.
* '''UnwindInsurance offinance discountexpenses''' impacted by higher unwind of claimsdiscount reservesof wasclaims higherreserves, in line with guidance <sup>p. 16</sup>.
* '''Forex impact''' was unfavorable, notably due to USD depreciation vs. EUR <sup>p. 16</sup>.
* '''Underwriting result components''' include volume growth (+EUR 292m) and margin improvement (+EUR 189m) <sup>p. 16</sup>.
* '''Financial result components''' include investment income (+EUR 435m) and insurance finance expenses (-EUR 235m) <sup>p. 16</sup>.
* (waterfall) '''Underlying earnings bridge''' FY24→FY25: EUR 5,510m start → volume growth +EUR 292m → margin improvement +EUR 189m → investment income +EUR 435m → insurance finance expenses -EUR 235m → tax -EUR 169m → affiliates, FX & other -EUR 150m → EUR 5,872m end (+9% at constant FX) <sup>p. 16</sup>.
 
=== Life & Health | Strong growth in premiums, positive net flows ===
Line 385 ⟶ 386:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Life GWP & other revenues and Net flows by segment, FY24 vs FY25 <sup>p. 17</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | LFL Change
! class="col-s" style="text-align:right" | Net flows
|-
| style="text-align:left" | '''Life GWP & other revenues'''
| style="text-align:right" | 34.5
| style="text-align:right" | 37.5
| style="text-align:right" | +9%
| style="text-align:right" | —
|-
| style="text-align:left" | Protection
Line 395 ⟶ 403:
| style="text-align:right" | 17.3
| style="text-align:right" | +11%
| style="text-align:right" | +4.9
|-
| style="text-align:left" | Unit-linked
Line 400 ⟶ 409:
| style="text-align:right" | 9.3
| style="text-align:right" | +13%
| style="text-align:right" | +1.5
|-
| style="text-align:left" | Capital light G/A
Line 405 ⟶ 415:
| style="text-align:right" | 9.0
| style="text-align:right" | +7%
| style="text-align:right" | +1.2
|-
| style="text-align:left" | Traditional G/A
Line 410 ⟶ 421:
| style="text-align:right" | 1.9
| style="text-align:right" | -7%
| style="text-align:right" | -5.0
|-
| style="text-align:left" | Employee benefitsBenefits
| style="text-align:right" | —
| style="text-align:right" | 12.9
| style="text-align:right" | +4%
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total'''Health GWP & other revenues'''
| style="text-align:right; font-weight:bold" | 3417.5
| style="text-align:right; font-weight:bold" | 3719.50
| style="text-align:right; font-weight:bold" | +95%
| style="text-align:right" | —
|}
</div>
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Health GWP & other revenues, FY24 vs FY25 <sup>p. 17</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | LFL Change
|-
| style="text-align:left" | Individual
Line 435 ⟶ 439:
| style="text-align:right" | 10.5
| style="text-align:right" | +6%
| style="text-align:right" | —
|-
| style="text-align:left" | Group
Line 440 ⟶ 445:
| style="text-align:right" | 8.5
| style="text-align:right" | +4%
|-
| style="text-align:left; font-weight:bold" | Total
| style="text-align:right; font-weight:bold" | 17.5
| style="text-align:right; font-weight:bold" | 19.0
| style="text-align:right; font-weight:bold" | +5%
|}
</div>
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Net flows, FY24 vs FY25 <sup>p. 17</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left" | Protection flows
| style="text-align:right" | —
| style="text-align:right" | +4.9
|-
| style="text-align:left" | Health flows
| style="text-align:right" | —
| style="text-align:right" | +2.7
|-
| style="text-align:left" | Unit-linked'''Total net flows'''
| style="text-align:right" | —
| style="text-align:right" | +1.5
| style="text-align:right" | +5.4
|-
| style="text-align:left" | Capital light flows
| style="text-align:right" | —
| style="text-align:right" | +1.2
|-
| style="text-align:left" | Traditional G/A flows
| style="text-align:right" | —
| style="text-align:right" | -5.0
|-
| style="text-align:left; font-weight:bold" | Total
| style="text-align:right; font-weight:bold" | +1.5
| style="text-align:right; font-weight:bold" | +5.4
|}
</div>
Line 485 ⟶ 459:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ PVEP, byNB segmentCSM, and NBV, FY24 vs FY25 <sup>p. 18</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | LFL Change
|-
| style="text-align:left" | '''PVEP'''
| style="text-align:right" | 50.9
| style="text-align:right" | 49.4
| style="text-align:right" | -2%
|-
| style="text-align:left" | Protection & Health
Line 496 ⟶ 475:
| style="text-align:right" | -4%
|-
| style="text-align:left" | Unit-linkedLinked
| style="text-align:right" | —
| style="text-align:right" | 8.5
Line 511 ⟶ 490:
| style="text-align:right" | -10%
|-
| style="text-align:left; font-weight:bold" | Total'''NB CSM (pre-tax)'''
| style="text-align:right; font-weight:bold" | 50.9
| style="text-align:right; font-weight:bold" | 49.4
| style="text-align:right; font-weight:bold" | -2%
|}
</div>
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ NB CSM (pre-tax), FY24 vs FY25 <sup>p. 18</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | LFL Change
|-
| style="text-align:left" | NB CSM (pre-tax)
| style="text-align:right" | 2.2
| style="text-align:right" | 2.2
| style="text-align:right" | +3%
|}
</div>
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ NBV (post-tax), FY24 vs FY25 <sup>p. 18</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | LFL Change
|-
| style="text-align:left" | '''NBV (post-tax)'''
| style="text-align:right" | 2.3
| style="text-align:right" | 2.2
| style="text-align:right" | stable
|-
| style="text-align:left" | NBV margin
| style="text-align:right" | 4.4%
| style="text-align:right" | 4.5%
| style="text-align:right" | —
|}
</div>
* '''PVEP''' was impacted by higher interest rates on discounting despite strong growth in Life volumes.
 
* '''PVEPNB CSM''' was impacteddriven by higherrobust interestSavings rates& onProtection discountingsales, despitewith strongreported growth inimpacted Lifeby higher interest rates for discounting volumesof <sup>p.future 18</sup>profits.
* '''NBV''' was broadly stable as strong growth in NB CSM balanced lower contribution from short-term multinational business in France.
* '''NB CSM''' was driven by robust Savings & Protection sales, with reported growth impacted by higher interest rates for discounting of future profits <sup>p. 18</sup>.
* '''NBV''' was broadly stable as strong growth in NB CSM balanced lower contribution from short-term multinational business in France <sup>p. 18</sup>.
* '''NBV margin''' improved to 4.5% (prior: 4.4%) <sup>p. 18</sup>.
 
=== Life & Health | Growth in new business driving Normalized CSM growth ===
Line 557 ⟶ 514:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ CSMContractual rollforward,Service FY24Margin to FY25rollforward <sup>p. 19</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | CSMContractual Service Margin
|-
| style="text-align:left" | FY24
| style="text-align:right" | 33.6
|-
| style="text-align:left" | newNew business CSM
| style="text-align:right" | +2.2
|-
| style="text-align:left" | underlyingUnderlying return on in-force
| style="text-align:right" | +1.3
|-
Line 573 ⟶ 530:
| style="text-align:right" | -3.0
|-
| style="text-align:left" | economicEconomic variance
| style="text-align:right" | +0.6
|-
| style="text-align:left" | operatingOperating variance
| style="text-align:right" | -0.3
|-
| style="text-align:left" | affiliatesAffiliates, FX & other
| style="text-align:right" | -1.4
|-
Line 587 ⟶ 544:
</div>
 
* '''Normalized CSM''' up by +2% LFL, with CSM release growth reflecting better margins and new business CSM growth impacted by higher rates <sup>p. 19</sup>.
* '''Economic variance''' reflectedreflecting government spreads tightening and positive equity market returns <sup>p. 19</sup>.
* '''Operating variance''' was driven by better margins and net flows that were more than offset by a reduction in the duration of Group Life business in Switzerland <sup>p. 19</sup>.
* '''FX impact''' was mainly driven byfrom JPY and HKD depreciation <sup>p. 19</sup>.
* FY24: o/w Life: EUR 25.8bn, o/w Health: EUR 7.7bn <sup>p. 19</sup>.
* FY25: o/w Life: EUR 25.4bn, o/w Health: EUR 7.6bn <sup>p. 19</sup>.
* '''Normalized CSM growth''' was +2% <sup>p. 19</sup>.
 
=== Life & Health | Strong momentum in both short-term and long-term business ===
Line 606 ⟶ 562:
| style="text-align:right" | 3,323
|-
| style="text-align:left" | shortShort-term technical margin
| style="text-align:right" | +60
|-
| style="text-align:left" | longLong-term result incl. CSM release
| style="text-align:right" | +156
|-
| style="text-align:left" | financialFinancial result
| style="text-align:right" | -11
|-
| style="text-align:left" | taxTax, FX and others
| style="text-align:right" | -27
|-
Line 623 ⟶ 579:
</div>
 
* '''Underlying earnings''' +7% LFL to EUR 3,501m.
* '''Short-term technical margin''' was strong, reflecting underwriting and claims initiatives that more than offset the impact of legislative change on the recoverability of value added tax in Mexico (EUR -0.1bn) <sup>p. 20</sup>.
* '''FY24 components''': Short-term technical margin EUR 415m; Long-term result incl. CSM release EUR 2,680m; Financial result EUR 975m; Tax & others -EUR 748m.
* '''Long-term results''' were higher from an increase in CSM release (+8%) reflecting growth in reserve base, including from favorable equity market performance, and better margins <sup>p. 20</sup>.
* '''FY25 components''': Short-term technical margin EUR 479m; Long-term result incl. CSM release EUR 2,804m; Financial result EUR 946m; Tax & others -EUR 728m.
* FY25 (+7% LFL) <sup>p. 20</sup>.
* '''Life segment''' underlying earnings EUR 2.7bn (+4% vs. FY24; FY24: EUR 2.6bn).
* '''FY24 earnings mix''': short-term technical margin EUR 415m, long-term result incl. CSM release EUR 2,680m, financial result EUR 975m, tax & others -EUR 748m <sup>p. 20</sup>.
* '''Health segment''' underlying earnings EUR 0.8bn (+17% vs. FY24; FY24: EUR 0.7bn).
* '''FY25 earnings mix''': short-term technical margin EUR 479m, long-term result incl. CSM release EUR 2,804m, financial result EUR 946m, tax & others -EUR 728m <sup>p. 20</sup>.
* '''Short-term technical margin''' strong on underwriting and claims initiatives; more than offset legislative change on VAT recoverability in Mexico of -EUR 0.1bn.
* '''Life underlying earnings''': FY24 EUR 2.6bn → FY25 EUR 2.7bn (+4% LFL) <sup>p. 20</sup>.
* '''Long-term results''' higher from CSM release increase of +8% on reserve base growth, favorable equity markets, and better margins.
* '''Health underlying earnings''': FY24 EUR 0.7bn → FY25 EUR 0.8bn (+17% LFL) <sup>p. 20</sup>.
 
=== Growth in net income reflecting higher earnings & the gain from the sale of AXA IM ===
Line 635 ⟶ 591:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Underlying earningsEarnings by segment, FY24 vs FY25 <sup>p. 21</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change (constant FX)
|-
| style="text-align:left" | Property & Casualty
Line 659 ⟶ 615:
| style="text-align:right" | -1.2
| style="text-align:right" | -1.2
| style="text-align:right" | flat
|-
| style="text-align:left" | Underlying earnings
| style="text-align:right" | 8.1
| style="text-align:right" | 8.4
| style="text-align:right" | +6%
|-
| style="text-align:left" | Non-financial flows
| style="text-align:right" | -0.5
| style="text-align:right" | 2.1
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | TotalFinancial flows underlying(including earningsRCG)
| style="text-align:right; font-weight:bold" | 80.13
| style="text-align:right; font-weight:bold" | 8-0.47
| style="text-align:right; font-weight:bold" | +6%
|-
| style="text-align:left" | Net income
| style="text-align:right" | 7.9
| style="text-align:right" | 9.8
| style="text-align:right" | +26%
|}
</div>
Line 670 ⟶ 641:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Underlying EPSearnings per share drivers, FY24 vsto FY25 <sup>p. 21</sup>
! style="text-align:left" | Driver
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" | UnderlyingEarnings EPS (reported basis)growth
| style="text-align:right" | 3.59
| style="text-align:right" | 3.86
| style="text-align:right" | +8%
|-
| style="text-align:left" | from earnings growth
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | +6%
|-
| style="text-align:left" | from capitalCapital management
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | +3%
|-
| style="text-align:left" | from forexForex
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | -2%
|-
| style="text-align:left" | from temporary earnings dilution from AXA IM sale
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | -1%
|}
</div>
 
* '''Underlying earnings''' driven by strong performance from insurance businesses.
* '''Non-financial flows''': EUR +2.1bn in FY25 vs EUR -0.5bn in FY24, including EUR +2.2bn capital gains from AXA IM disposal <sup>p. 21</sup>.
* '''Holding cost''' stable, expected to remain at current level in 2026.
* '''Financial flows''': EUR -0.7bn in FY25 (including realized capital gains) vs EUR +0.3bn in FY24 <sup>p. 21</sup>.
* '''Net income''': EURgrowth 9.8bnmainly inreflecting FY25higher vsunderlying EURearnings 7.9bnand inthe FY24gain (+26%from atthe constantsale FX)of <sup>p.AXA 21</sup>IM.
* '''Financial flows''' lower reflecting unfavorable forex impact.
* '''Insurance business performance''': Strong performance from insurance businesses <sup>p. 21</sup>.
* '''Capital gains''' from AXA IM disposal: EUR +2.2bn in FY25.
* '''Holding costs''': Stable holding cost, expected to remain at current level in 2026 <sup>p. 21</sup>.
* '''Temporary dilution''' from AXA IM sale: -1% included in forex/capital management, due to the timing of anti-dilutive share buyback.
* '''Net income drivers''': Higher net income mainly reflecting higher underlying earnings and the gain from the sale of AXA IM; lower financial flows reflecting unfavorable forex impact <sup>p. 21</sup>.
* Includes(bar <code>-1%</code> fromchart) temporary'''Underlying earnings dilutionper fromshare''' AXA(in IMEuro, salereported duebasis): EUR 3.59 in FY24 to theEUR timing3.86 ofin anti-dilutiveFY25 share buyback(+8%) <sup>p. 21</sup>.
 
== FY25 Financial Performance ==
 
=== Shareholders' Equity ===
 
* All figures in Euro billion unless otherwise stated <sup>p. 22</sup>.
<div style="overflow-x:auto">
* (stacked bar) '''Shareholders' equity''' (Group share):
{| class="wikitable fintable"
|+** Shareholders'''FY24''': equityEUR 49.9bn total (comprising SHE excl. OCI of EUR 58.0bn and relatedNet OCI of EUR metrics-8.1bn) <sup>p. 22</sup>
** '''HY25''': EUR 45.5bn total (comprising SHE excl. OCI of EUR 52.7bn and Net OCI of EUR -7.2bn) <sup>p. 22</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
** '''FY25''': EUR 47.2bn total (comprising SHE excl. OCI of EUR 54.0bn and Net OCI of EUR -6.8bn) <sup>p. 22</sup>
! class="col-s" style="text-align:right" | FY24
* '''SHE (excl. OCI & undated subordinated debt)''': EUR 53.2bn in FY24; EUR 47.0bn in HY25; EUR 49.4bn in FY25 <sup>p. 22</sup>
! class="col-s" style="text-align:right" | HY25
* '''Debt gearing''': 20.6% in FY24; 23.4% in HY25; 22.3% in FY25 <sup>p. 22</sup>
! class="col-s" style="text-align:right" | FY25
* '''Underlying ROE''': 15.2% in FY24; 17.5% in HY25; 16.0% in FY25 <sup>p. 22</sup>
|-
| style="text-align:left" |* '''Shareholders' equity (Group share)bridge''':
** '''Opening Shareholders' equity''': EUR 49.9bn (FY24 to FY25); EUR 45.5bn (HY25 to FY25) <sup>p. 22</sup>
| style="text-align:right" | 49.9
** '''Change in Net OCI''': +EUR 1.3bn (FY24 to FY25); +EUR 0.4bn (HY25 to FY25) <sup>p. 22</sup>
| style="text-align:right" | 45.5
** '''Net income for the period''': +EUR 9.8bn (FY24 to FY25); +EUR 5.9bn (HY25 to FY25) <sup>p. 22</sup>
| style="text-align:right" | 47.2
** '''Dividend''': -EUR 4.6bn (FY24 to FY25); nil (HY25 to FY25) <sup>p. 22</sup>
|-
** '''Annual share buyback''': -EUR 1.2bn (FY24 to FY25); nil (HY25 to FY25) <sup>p. 22</sup>
| style="text-align:left" | SHE excl. OCI
** '''Anti-dilutive share buyback following the sale of AXA IM''': -EUR 3.5bn (FY24 to FY25); -EUR 3.5bn (HY25 to FY25) <sup>p. 22</sup>
| style="text-align:right" | 58.0
** '''Undated subordinated debt (including interest charges)''': -EUR 0.3bn (FY24 to FY25); -EUR 1.2bn (HY25 to FY25) <sup>p. 22</sup>
| style="text-align:right" | 52.7
** '''Forex''': -EUR 3.5bn (FY24 to FY25); -EUR 0.1bn (HY25 to FY25) <sup>p. 22</sup>
| style="text-align:right" | 54.0
** '''Other''': -EUR 0.6bn (FY24 to FY25); +EUR 0.3bn (HY25 to FY25) <sup>p. 22</sup>
|-
** '''Closing Shareholders' equity''': EUR 47.2bn (FY24 to FY25); EUR 47.2bn (HY25 to FY25) <sup>p. 22</sup>
| style="text-align:left" | Net OCI
| style="text-align:right" | -8.1
| style="text-align:right" | -7.2
| style="text-align:right" | -6.8
|-
| style="text-align:left" | SHE (excl. OCI & undated subordinated debt)
| style="text-align:right" | 53.2
| style="text-align:right" | 47.0
| style="text-align:right" | 49.4
|-
| style="text-align:left" | Debt gearing
| style="text-align:right" | 20.6%
| style="text-align:right" | 23.4%
| style="text-align:right" | 22.3%
|-
| style="text-align:left" | Underlying ROE
| style="text-align:right" | 15.2%
| style="text-align:right" | 17.5%
| style="text-align:right" | 16.0%
|}
</div>
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Shareholders' equity bridge, FY24 to FY25 <sup>p. 22</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | Value
|-
| style="text-align:left" | Opening SHE
| style="text-align:right" | 49.9
|-
| style="text-align:left" | Change in Net OCI
| style="text-align:right" | +1.3
|-
| style="text-align:left" | Net income
| style="text-align:right" | +9.8
|-
| style="text-align:left" | Dividend
| style="text-align:right" | -4.6
|-
| style="text-align:left" | Annual share buyback
| style="text-align:right" | -1.2
|-
| style="text-align:left" | Anti-dilutive share buyback
| style="text-align:right" | -3.5
|-
| style="text-align:left" | Undated subordinated debt
| style="text-align:right" | -0.3
|-
| style="text-align:left" | Forex
| style="text-align:right" | -3.5
|-
| style="text-align:left" | Other
| style="text-align:right" | -0.6
|-
| style="text-align:left" | Closing SHE
| style="text-align:right" | 47.2
|}
</div>
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Shareholders' equity bridge, HY25 to FY25 <sup>p. 22</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | Value
|-
| style="text-align:left" | Opening SHE
| style="text-align:right" | 45.5
|-
| style="text-align:left" | Change in Net OCI
| style="text-align:right" | +0.4
|-
| style="text-align:left" | Net income
| style="text-align:right" | +5.9
|-
| style="text-align:left" | Anti-dilutive share buyback
| style="text-align:right" | -3.5
|-
| style="text-align:left" | Undated subordinated debt
| style="text-align:right" | -1.2
|-
| style="text-align:left" | Forex
| style="text-align:right" | -0.1
|-
| style="text-align:left" | Other
| style="text-align:right" | +0.3
|-
| style="text-align:left" | Closing SHE
| style="text-align:right" | 47.2
|}
</div>
 
=== Higher organic cash remittance and robust cash position at Holding ===
Line 829 ⟶ 690:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Net cashCash remittanceRemittance <sup>p. 23</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left" | Net cashCash remittanceRemittance
| style="text-align:right" | 7.7
| style="text-align:right" | 7.5
|-
| style="text-align:left" | Ordinary cash remittance
| style="text-align:right" | 7.1
| style="text-align:right" | 7.5
|-
| style="text-align:left" | InProceeds related to in-force treaties proceeds
| style="text-align:right" | 0.6
| style="text-align:right" | —
Line 848 ⟶ 709:
</div>
 
* Remittance ratio was 82% in FY24 and 82% in FY25 <sup>p. 23</sup>
* In-force treaties proceeds in FY24 related to L&S reinsurance in-force treaties at AXA France and AXA Life Europe.
* Proceeds related to in-force treaties of EUR 0.6bn in FY24 related to L&S reinsurance in-force treaties at AXA France and AXA Life Europe <sup>p. 23</sup>
* Remittance ratio: 82% in FY25 (FY24: 82%)
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Holding cash position bridge, FY24 to FY25 <sup>p. 23</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | Value
Line 860 ⟶ 721:
| style="text-align:right" | 4.0
|-
| style="text-align:left" | Net cash remittance from subsidiaries
| style="text-align:right" | +7.5
|-
Line 869 ⟶ 730:
| style="text-align:right" | -1.2
|-
| style="text-align:left" | Anti-dilutive share buyback following the sale of AXA IM
| style="text-align:right" | -3.5
|-
| style="text-align:left" | Holding costs and interest expenses
| style="text-align:right" | -1.3
|-
Line 885 ⟶ 746:
|}
</div>
 
* Holding costs include interest expenses.
* Anti-dilutive share buyback following the sale of AXA IM.
 
=== Solvency II at 224% ===
Line 895 ⟶ 753:
|+ Solvency II walk, FY24 to FY25 <sup>p. 24</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | EOFSolvency II ratio (pts)
! class="col-s" style="text-align:right" | SCREligible Own Funds (EOF)
! class="col-s" style="text-align:right" | Solvency IICapital ratioRequirement (%SCR)
|-
| style="text-align:left" | FY24
| style="text-align:right" | 216
| style="text-align:right" | 55.9
| style="text-align:right" | 25.9
| style="text-align:right" | 216
|-
| style="text-align:left" | Regulatory & model changes
| style="text-align:right" | +0
| style="text-align:right" | +0.2
| style="text-align:right" | 0.0
| style="text-align:right" | +0
|-
| style="text-align:left" | Normalized capital generation
| style="text-align:right" | +28
| style="text-align:right" | +8.8
| style="text-align:right" | +0.6
| style="text-align:right" | +28
|-
| style="text-align:left" | Operating variance
| style="text-align:right" | -1
| style="text-align:right" | -0.4
| style="text-align:right" | 0.0
| style="text-align:right" | -1
|-
| style="text-align:left" | Economic variance & FX
| style="text-align:right" | +4
| style="text-align:right" | -2.1
| style="text-align:right" | -1.2
| style="text-align:right" | +4
|-
| style="text-align:left" | Dividend & annual share buyback
| style="text-align:right" | -24
| style="text-align:right" | -6.0
| style="text-align:right" | 0.0
| style="text-align:right" | -24
|-
| style="text-align:left" | Management actions, debt & other
| style="text-align:right" | +2
| style="text-align:right" | -0.1
| style="text-align:right" | -0.2
| style="text-align:right" | +2
|-
| style="text-align:left" | FY25
| style="text-align:right" | 224
| style="text-align:right" | 56.4
| style="text-align:right" | 25.2
| style="text-align:right" | 224
|}
</div>
 
* Dividend & annual share buyback comprisesincludes foreseeable dividends of EUR -4.8bn and provision for annual share buyback for 2026 of EUR -1.25bn <sup>p. 24</sup>.
* Management actions include debt & other.
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Solvency II sensitivities (impact on 224% base ratio as of December 31, 2025) <sup>p. 24</sup>
! style="text-align:left" | Sensitivity
! class="col-s" style="text-align:right" | Impact (pts)
Line 965 ⟶ 822:
| style="text-align:right" | -4
|-
| style="text-align:left" | Listed Equity +25% (excl. PE & Infra) +25%
| style="text-align:right" | -1
|-
| style="text-align:left" | Listed Equity -25% (excl. PE & Infra) -25%
| style="text-align:right" | +2
|-
Line 982 ⟶ 839:
</div>
 
* Euro Sovereign spreads +50bps assumes 50bps spread widening of Euro sovereign bonds vs. Euro swap curve applied on sovereign and quasi-sovereign exposures <sup>p. 24</sup>
* Credit migration assumes 20% of corporate bonds, including private debt, held are downgraded by one full letter / 3 notches <sup>p. 24</sup>
 
=== Solvency II -impact of the end of grandfathering period and Solvency II revision ===
 
<div style="overflow-x:auto">
* '''Solvency II ratio''' as of December 31, 2025: 224% <sup>p. 25</sup>
{| class="wikitable fintable"
* '''Grandfathering period end''': Impact of -10pts to 215% on January 1, 2026 <sup>p. 25</sup>
|+ Solvency II ratio evolution <sup>p. 25</sup>
** EUR 2.4bn grandfathered debt is no longer eligible as capital from January 1, 2026 <sup>p. 25</sup>
! style="text-align:left" | Solvency II ratio
* '''Solvency II revision''': Estimated impact of +17pts (to come into effect in 1Q27) <sup>p. 25</sup>
! class="col-s" style="text-align:right" | Value
** No change expected in organic capital generation <sup>p. 25</sup>
|-
** Additional capital flexibility <sup>p. 25</sup>
| style="text-align:left" | As of December 31, 2025
** Estimated based on SCR and EOF under Solvency II as of January 1, 2026, as if the revision had come into force on that date <sup>p. 25</sup>
| style="text-align:right" | 224%
|-
| style="text-align:left" | Grandfathering end impact on January 1, 2026
| style="text-align:right" | -10pts
|-
| style="text-align:left" | Ratio after grandfathering impact
| style="text-align:right" | 215%
|-
| style="text-align:left" | Solvency II revision impact (estimated)
| style="text-align:right" | +17pts
|}
</div>
 
* EUR 2.4bn grandfathered debt is no longer eligible as capital from January 1, 2026.
* No change is expected in organic capital generation.
* Provides additional capital flexibility.
* ¹ Estimated based on the Solvency Capital Requirement (SCR) and the amount of capital (EOF) under Solvency II as of January 1, 2026, as if the Solvency II revision had come into force on the same date.
* '''Solvency II revision''' impact to come into effect in 1Q27 is estimated at +17pts¹ <sup>p. 25</sup>.
 
=== Thomas Buberl, Group CEO conclusion ===
 
* '''Section dividerConclusion''' featuringpresented by Thomas Buberl, Group CEO <sup>p. 26</sup>
 
=== Conclusion ===
 
* '''Record results''' achieved at the top end of the target range while enhancing reserve prudence <sup>p. 27</sup>.
* '''AllBusiness businessesperformance''' shows all businesses in excellent shape, delivering strong growth and profitability <sup>p. 27</sup>.
* '''Diversified franchise''' is well-positioned to capture future growth opportunities <sup>p. 27</sup>.
* '''LayingStrategic foundationsoutlook''' focused on laying foundations for the next plan and confident in delivering sustainable earnings growth <sup>p. 27</sup>.
 
=== February 26, 2026 Q&A Full Year 2025 earnings ===
 
* '''SectionQ&A dividersession''' for Q&Athe sessionFull Year 2025 Earnings presentation held on February 26, 2026 <sup>p. 28</sup>
 
=== AXA Investor Relations | Keep in touch ===
 
* '''Investor Relations contact''': +33 1 40 75 48 42; investor.relations@axa.com <sup>p. 29</sup>
* '''Meet our management''' event calendar:
** March'''Follow us''': Roadshows in Europe and USwww.axa.com <sup>p. 29</sup>
* '''Financial calendar''':
** May 5: 1Q25 Activity Indicators in Paris <sup>p. 29</sup>
** June 2'''March''': BNP Paribas Exane CEORoadshows Conference(Europe inand ParisUS) <sup>p. 29</sup>
** June'''May 2-45''': Goldman1Q25 SachsActivity EuropeanIndicators Financials Conference in Zurich(Paris) <sup>p. 29</sup>
** July'''June 312''': HY26BNP EarningsParibas ReleaseExane inCEO Conference (Paris) <sup>p. 29</sup>
** September'''June 212-4''': AXAGoldman InvestorSachs DayEuropean inFinancials LondonConference (Zurich) <sup>p. 29</sup>
** '''ContactJuly us31''' details: Investor Relations phone +33 1 40 75 48HY26 42;Earnings emailRelease investor.relations@axa.com(Paris) <sup>p. 29</sup>
** '''FollowSeptember us21''' website: www.axa.comAXA Investor Day (London) <sup>p. 29</sup>
 
== Appendices ==
 
* '''Section divider slide introducing the '''Appendices''' for appendicessection <sup>p. 30</sup>.
 
* '''Debt and Invested Assets''' <sup>p. 31</sup>
<div style="overflow-x:auto">
* '''Additional P&C disclosures''' <sup>p. 36</sup>
{| class="wikitable fintable"
|+* '''Additional IFRS17 disclosures by topic and page''' <sup>p. 3141</sup>
* '''Sustainability''' <sup>p. 44</sup>
! style="text-align:left" | Topic
! class="col-s" style="text-align:right" | Page
|-
| style="text-align:left" | Debt and Invested Assets
| style="text-align:right" | 31
|-
| style="text-align:left" | Additional P&C disclosures
| style="text-align:right" | 36
|-
| style="text-align:left" | Additional IFRS17 disclosures
| style="text-align:right" | 41
|-
| style="text-align:left" | Sustainability
| style="text-align:right" | 44
|}
</div>
 
=== Gross financial debt and maturity breakdown as of December 31st, 2025 ===
 
* '''Debt gearing''' was 20.6% in FY24 and 22.3% in FY25 <sup>p. 32</sup>.
* (stacked bar) '''Gross financial debt''':
* (stacked bar) '''Gross financial debt''' (nominal debt basis):
** '''FY24''': EUR 19.2bn total (Tier 1: EUR 4.8bn, Tier 2: EUR 10.8bn, Senior debt: EUR 3.5bn); debt gearing at 20.6% <sup>p. 32</sup>
** '''FY25FY24''': EUR 2019.3bn2bn total (Tier 1: EUR 4.6bn8bn, Tier 2: EUR 1210.2bn8bn, Senior debt: EUR 3.5bn); debt gearing at 22.3% <sup>p. 32</sup>
** '''Jan 1st 2026FY25''' (End of the grandfathering period): EUR 20.3bn total (Tier 1: EUR 34.2bn6bn, Tier 2: EUR 1112.3bn2bn, Senior debt: EUR 53.8bn, of which EUR 0.4bn redeemed in Jan 20265bn) <sup>p. 32</sup>
** '''Jan 1st 2026''' (End of the grandfathering period): EUR 20.3bn total (Tier 1: EUR 3.2bn, Tier 2: EUR 11.3bn, Senior debt: EUR 5.8bn; of which EUR 0.4bn redeemed in Jan 2026) <sup>p. 32</sup>
* (bar chart) '''Contractual maturity breakdown''':
* (stacked bar) '''Contractual maturity breakdown''' (EUR billion):
** '''2028''': EUR 0.5bn (Senior debt) <sup>p. 32</sup>
** '''2030''': EUR 0.9bn total (Tier 2: EUR 0.7bn, Senior debt: EUR 0.2bn) <sup>p. 32</sup>
Line 1,058 ⟶ 919:
** '''≥2040''': EUR 11.3bn total (Tier 2: EUR 10.8bn, Senior debt: EUR 0.5bn) <sup>p. 32</sup>
** '''Undated''': EUR 5.3bn total (Tier 1: EUR 4.6bn, Tier 2: EUR 0.7bn) <sup>p. 32</sup>
** '''Of which Grandfatheredgrandfathered debt (Contractual)''': Tier 1 Undated: EUR 1.4bn; Tier 2 2030: EUR 0.7bn, ≥2040: EUR 0.2bn <sup>p. 32</sup>
* (barstacked chartbar) '''Economic maturity breakdown''' (taking into account first date of step-up calls on institutionally placed subordinated debt):
** '''2026''': EUR 0.1bn (Tier 1) <sup>p. 32</sup>
** '''2027''': EUR 2.4bn (Tier 2) <sup>p. 32</sup>
Line 1,065 ⟶ 926:
** '''2029''': EUR 2.0bn (Tier 2) <sup>p. 32</sup>
** '''2030''': EUR 0.9bn total (Tier 2: EUR 0.7bn, Senior debt: EUR 0.2bn) <sup>p. 32</sup>
** '''2031-2039''': EUR 1.5bn9bn total (Tier 1: EUR 0.4bn, Tier 2: EUR 6.4bn [unclear], Senior debt: EUR 1.1bn5bn) <sup>p. 32</sup>
** '''≥2040''': EUR 0.5bn (Senior debt) <sup>p. 32</sup>
** '''Undated''': EUR 4.7bn total (Tier 1: EUR 4.0bn, Tier 2: EUR 0.7bn) <sup>p. 32</sup>
** '''Of which Grandfatheredgrandfathered debt (Economic)''': Tier 1: 2026: EUR 0.1bn, 2028: EUR 0.1bn, 2031-2039: EUR 0.4bn, Undated: EUR 0.8bn; Tier 2: 2030: EUR 0.7bn, ≥2040: EUR 0.2bn <sup>p. 32</sup>
* '''Redemption actions''': In January 2026, AXA called the remaining T2Tier GF2 grandfathered GBP 139m due 2054 callable 2034 5.625% issued January 2014, and the T1Tier 1 GFgrandfathered EUR 250m perpetual callable 2010 floating issued January 2005 <sup>p. 32</sup>.
* '''Economic maturity definition''': Takes into account the first date of step-up calls on institutionally placed subordinated debt; Solvency II RT1 debt has no step-up, so its undated nature is retained <sup>p. 32</sup>.
 
=== General Account invested assets ===
Line 1,076 ⟶ 936:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ FY25 Total General Account invested assets <sup>p. 33</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | Value
Line 1,085 ⟶ 945:
| style="text-align:right" | 77%
|-
| style="text-align:left; padding-left:1.5em" | o/w Government bonds
| style="text-align:right" | 167
| style="text-align:right" | 37%
|-
| style="text-align:left; padding-left:1.5em" | o/w Corporate bonds and loans
| style="text-align:right" | 121
| style="text-align:right" | 27%
|-
| style="text-align:left; padding-left:1.5em" | o/w Other fixed income
| style="text-align:right" | 56
| style="text-align:right" | 13%
Line 1,127 ⟶ 987:
</div>
 
* Total General Account invested assets: EUR 450bn total, with a duration gap at -0.4 year
* Other fixed income includes Asset Backed Securities (of EUR 25bn), Residential Loans (of EUR 16bn), Commercial & Agricultural Loans (of EUR 7bn), and Agency Pools (of EUR 8bn)
* Listed equities includes hedges; (listed equities excluding hedges at EUR 14bn)
* Private equity and hedge funds includes Private Equity (of EUR 17bn), Hedge Funds (of EUR 5bn), and Non-listed Equities (of EUR 1bn)
 
=== Structured and Private Credit assets ===
Line 1,136 ⟶ 996:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Structured assets and Privateprivate Creditcredit Assetsassets <sup>p. 34</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | Value
! class="col-s" style="text-align:right" | %Share of total G/A portfolio
|-
| style="text-align:left" | Residential Mortgagesmortgages
| style="text-align:right" | 16
| style="text-align:right" | 4%
Line 1,157 ⟶ 1,017:
| style="text-align:right" | 2%
|-
| style="text-align:left" | Mid-Marketmarket lending
| style="text-align:right" | 10
| style="text-align:right" | 2%
|-
| style="text-align:left" | Other assets
| style="text-align:right" | 2
| style="text-align:right" | 0%
|-
| style="text-align:left; font-weight:bold" | Total Structuredstructured assets and Privateprivate Creditcredit Assetsassets
| style="text-align:right; font-weight:bold" | 69
| style="text-align:right; font-weight:bold" | 15%
Line 1,171 ⟶ 1,031:
</div>
 
* Residential Mortgages:mortgages includes EUR 6bn Dutch mortgages, NHG guaranteed; EUR 10bn self-originated mortgages in Switzerland (56% LTV) and Germany (45% LTV)
* Residential mortgages includes EUR 10bn self-originated mortgages in Switzerland (56% LTV) and Germany (45% LTV)
* CLO & ABS: 91% senior CLOs with circa 40% subordination (100% rated AAA-A and 92% rated AAA-AA)
* Infrastructure debt: skewed towards resilient industries (including Telecom, Utilities, and Transport)
* CRE debt: strong sector diversification (mainly logistics, residential, and retail), mostly in Europe, and circa 60% LTV
* Mid-Marketmarket lending: strong diversification with EUR 8m average ticket; investments through SMAs with strict underwriting guidelines: senior secured, covenants, restrictions on asset sales and sector allocation
* Mid-market lending: investments through SMAs with strict underwriting guidelines: senior secured, covenants, restrictions on asset sales, and sector allocation
* Total Structured and Private Credit Assets: 54% participating
* Total structured assets and private credit assets: 54% is participating
 
=== Investment portfolio | Fixed Income reinvestment ===
Line 1,182 ⟶ 1,044:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ FY25 Fixed Incomeincome Reinvestmentreinvestment asset mix and yield, FY25 <sup>p. 35</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | ShareReinvestment asset mix
! class="col-s" style="text-align:right" | YieldAverage rating
! class="col-s" style="text-align:right" | Reinvestment yield
|-
| style="text-align:left" | Government bonds & related
| style="text-align:right" | 32%
| style="text-align:right" | AA
| style="text-align:right" | —
|-
| style="text-align:left" | Investment grade credit
| style="text-align:right" | 40%
| style="text-align:right" | A
|-
| style="text-align:left" | Government bonds & related
| style="text-align:right" | 32%
| style="text-align:right" | —
|-
| style="text-align:left" | ABS/CLO/IG fund financing
| style="text-align:right" | 21%
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Below investment grade credit
| style="text-align:right" | 7%
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Public fixed income
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 3.5%
|-
| style="text-align:left" | Private & Structured fixed income
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 4.7%
|-
| style="text-align:left; font-weight:bold" | Total fixed income
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | 3.9%
Line 1,217 ⟶ 1,087:
</div>
 
* Fixed income reinvestment totaled EUR 57bn in FY25.
* Reinvestment highlights:
* Reinvestment duration averaged 9 years.
** EUR 57bn fixed income invested at 3.9% <sup>p. 35</sup>
* Private & Structured credit reinvestment was EUR 19.7bn at 4.7% yield, covering CLOs, ABS, Infra & CRE debt, Fund financing, and Private HY.
** Average duration of 9 years <sup>p. 35</sup>
* Strategic asset shift from alternative total return assets to Private & Structured credit.
** Includes EUR 19.7bn of Private & Structured Credit invested at 4.7% (CLOs, ABS, Infra & CRE debt, Fund financing and Private HY) <sup>p. 35</sup>
** Gradual shift from alternative total return assets to Private & Structured credit <sup>p. 35</sup>
 
* '''AdditionalTable P&Cof disclosurescontents''' issection covered on page 36divider <sup>p. 36</sup>.:
** Other sections in the appendix include1. Debt and Invested Assets on page 31, Additional IFRS17 disclosures on page 41, and Sustainability on page 44 <sup>p. 3631</sup>.
** 2. '''Additional P&C disclosures''' <sup>p. 36</sup>
** 3. Additional IFRS17 disclosures <sup>p. 41</sup>
** 4. Sustainability <sup>p. 44</sup>
 
=== AXA XL Insurance | Large Commercial & Specialty business ===
Line 1,230 ⟶ 1,102:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ FY25 GWP breakdownby line of business and geography <sup>p. 37</sup>
! style="text-align:left" | USD billion unless otherwise mentioned
! class="col-s" style="text-align:right" | GWP by lineShare
|-
! class="col-s" style="text-align:right" | GWP by geography
| style="text-align:left" | '''GWP by line of business'''
| style="text-align:right" | —
|-
| style="text-align:left" | Casualty
| style="text-align:right" | 35%
| style="text-align:right" | —
|-
| style="text-align:left" | Property
| style="text-align:right" | 29%
| style="text-align:right" | —
|-
| style="text-align:left" | Specialty
| style="text-align:right" | 19%
| style="text-align:right" | —
|-
| style="text-align:left" | Professional lines (including Cyber)
| style="text-align:right" | 17%
|-
| style="text-align:left" | '''GWP by geography'''
| style="text-align:right" | —
|-
| style="text-align:left" | Americas
| style="text-align:right" | —
| style="text-align:right" | 46%
|-
| style="text-align:left" | Europe & APAC
| style="text-align:right" | —
| style="text-align:right" | 35%
|-
| style="text-align:left" | UK & Lloyds
| style="text-align:right" | —
| style="text-align:right" | 19%
|}
</div>
* AXA XL Insurance is well diversified across lines of business and geographies, with USD 19bn FY25 GWP.
 
* Market leadership positions AXA XL as top 3 globally in:
* Market position: Top 3 globally in Multinational Programs, Marine, and Fine Art & Specie <sup>p. 37</sup>.
** Multinational Programs
* (bubble chart) Cycle management: Property has the highest profitability and highest ex-price growth; Specialty has medium profitability and medium ex-price growth; Casualty has medium-low profitability and medium-low ex-price growth; Professional lines has the lowest profitability and lowest ex-price growth <sup>p. 37</sup>.
** Marine
** Fine Art & Specie
* (bubble chart) '''Managing the cycle''' to deliver consistent profitability (Profitability vs Ex-price growth %):
** '''Property''': Highest profitability and highest ex-price growth
** '''Specialty''': Medium-high profitability and medium-high ex-price growth
** '''Casualty''': Medium-low profitability and medium-low ex-price growth
** '''Professional lines''': Lowest profitability and lowest ex-price growth
 
=== P&C | Focus on Reserves ===
Line 1,272 ⟶ 1,149:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Claims and technicalTechnical reserves ratios by IFRS basisratio <sup>p. 38</sup>
! style="text-align:left" | %
! class="col-s" style="text-align:right" | FY18Claims reserves ratio (IFRS4)
! class="col-s" style="text-align:right" | FY19Claims reserves ratio (IFRS17)
! class="col-s" style="text-align:right" | FY20Technical reserves ratio (IFRS4)
! class="col-s" style="text-align:right" | FY21Technical reserves ratio (IFRS17)
! class="col-s" style="text-align:right" | FY22
! class="col-s" style="text-align:right" | FY23
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left" | Claims reserves ratio (IFRS4)FY18
| style="text-align:right" | 179%
| style="text-align:right" | 185%
| style="text-align:right" | 193%
| style="text-align:right" | 188%
| style="text-align:right" | 189%
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 213
| style="text-align:right" | —
|-
| style="text-align:left" | Claims reserves ratio (IFRS17)FY19
| style="text-align:right" | 185
| style="text-align:right" | —
| style="text-align:right" | 227
| style="text-align:right" | —
|-
| style="text-align:left" | FY20
| style="text-align:right" | 193
| style="text-align:right" | —
| style="text-align:right" | 233
| style="text-align:right" | —
| style="text-align:right" | 198%
| style="text-align:right" | 195%
| style="text-align:right" | 180%
| style="text-align:right" | 175%
|-
| style="text-align:left" | Technical reserves ratio (IFRS4)FY21
| style="text-align:right" | 213%188
| style="text-align:right" | 227%
| style="text-align:right" | 233%
| style="text-align:right" | 226%
| style="text-align:right" | 227%
| style="text-align:right" | —
| style="text-align:right" | 226
| style="text-align:right" | —
|-
| style="text-align:left" | FY22
| style="text-align:right" | 189
| style="text-align:right" | 198
| style="text-align:right" | 227
| style="text-align:right" | 234
|-
| style="text-align:left" | FY23
| style="text-align:right" | —
| style="text-align:right" | 195
| style="text-align:right" | —
| style="text-align:right" | 232
|-
| style="text-align:left" | Technical reserves ratio (IFRS17)FY24
| style="text-align:right" | —
| style="text-align:right" | 180
| style="text-align:right" | —
| style="text-align:right" | 216
|-
| style="text-align:left" | FY25
| style="text-align:right" | —
| style="text-align:right" | 175
| style="text-align:right" | —
| style="text-align:right" | 234%210
| style="text-align:right" | 232%
| style="text-align:right" | 216%
| style="text-align:right" | 210%
|}
</div>
* Technical reserves include net undiscounted claims reserves and unearned premium reserves.
 
=== P&C | 2026 Simplified Group Nat Cat Reinsurance Program 1 ===
Line 1,329 ⟶ 1,211:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ ReinsuranceInsurance segment occurrence protection capacity and retention by peril <sup>p. 39</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | Capacity
Line 1,354 ⟶ 1,236:
| style="text-align:right" | 600m
|-
| style="text-align:left" | OtherPer other perils
| style="text-align:right" | —
| style="text-align:right" | 400m
Line 1,360 ⟶ 1,242:
</div>
 
* '''Retention levels:''' Stableremained retention levels maintainedstable in 2026 ascompared into 2025 <sup>p. 39</sup>.
* (diagram) '''Reinsurance segment''' (illustrative) utilizes Alternative Capital & Cat Bonds <sup>p. 39</sup>.
* NA Hurricane: varying retention between MX at EUR 400m and NA at EUR 600m.
* NA Earthquake: varying retention between MX at EUR 400m and NA at EUR 600m.
* Other perils: includes Turkey earthquake, other Europe and NA perils, South America Earthquake, and other secondary perils.
* Reinsurance segment: Alternative Capital & Cat Bonds utilized.
 
=== P&C | AXA Group earnings deviation with different levels of Nat Cat cost 1 in 2026 ===
 
* '''Earnings deviation''' to average Nat Cat charges in 2026 (net of reinsurance, post-tax) shows negative deviation in ca. 40% of cases (more severe years) and positive deviation in ca. 60% of cases (less severe years) <sup>p. 40</sup>.
* '''Nat Cat definition''': Natural catastrophe cost defined as Aggregate Exceedance Probability (AEP) of all natural perils worldwide, net of tax and reinsurance <sup>p. 40</sup>.
* (bar chart) '''Group underlying earnings''' deviation to average Nat Cat charges in 2026:
* '''Deviation baseline''': Compared to a normalized level of costs expected in an average year, which is ca. 4.5 points of estimated FY25 GEP, undiscounted and net of reinsurance <sup>p. 40</sup>.
** '''1/20y (95th percentile)''': EUR -1.2bn <sup>p. 40</sup>
* (bar) '''Earnings deviation''': Group underlying earnings deviation to average Nat Cat charges in 2026 net of reinsurance, post-tax <sup>p. 40</sup>.
** '''More severe years''': Negative deviation in ca. 40% of cases; 1/20y (95th percentile) EUR -1.2bn, 1/10y (90th percentile)''': EUR -0.8bn, 1/5y (80th percentile) EUR -0.4bn <sup>p. 40</sup>.
** '''Median1/5y (80th percentile)''': 50th percentile at EUR +-0.1bn4bn <sup>p. 40</sup>.
** '''Median (50th percentile)''': EUR +0.1bn <sup>p. 40</sup>
** '''Less severe years''': Positive deviation in ca. 60% of cases; 1/5y (20th percentile) EUR +0.5bn, 1/10y (10th percentile) EUR +0.7bn, 1/20y (5th percentile) EUR +0.8bn <sup>p. 40</sup>.
* (bar)* '''Expected1/5y Nat(20th Catpercentile)''': AverageEUR expected Nat Cat charges net of reinsurance, pre-tax+0.5bn <sup>p. 40</sup>.
** '''FY251/10y (10th percentile)''': EUR 2+0.6bn (Estimated impact on GEP: ca. 4.5%)7bn <sup>p. 40</sup>.
** '''FY261/20y (5th percentile)''': EUR 2+0.7bn (Estimated impact on GEP: ca. 4.5%)8bn <sup>p. 40</sup>.
* (bar chart) '''Average expected Nat Cat''' charges (net of reinsurance, pre-tax):
** '''2025''': 2.6, with estimated impact on GEP of ca. 4.5% <sup>p. 40</sup>
** '''2026''': 2.7, with estimated impact on GEP of ca. 4.5% <sup>p. 40</sup>
* '''Natural catastrophe cost''' is defined as Aggregate Exceedance Probability (AEP) of all natural perils worldwide, net of tax and reinsurance <sup>p. 40</sup>.
* '''Deviation comparison''' is made to a normalized level, which represents costs associated with natural catastrophes expected in an average year, at ca. 4.5 points of estimated FY25 GEP, undiscounted and net of reinsurance <sup>p. 40</sup>.
 
* '''Table of contents''' section divider <sup>p. 41</sup>:
** 1. Debt and Invested Assets <sup>p. 31</sup>
** 2. Additional P&C disclosures <sup>p. 36</sup>
Line 1,388 ⟶ 1,272:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ P&C margin analysis, FY25 vs FY24 at constant FX <sup>p. 42</sup>
! style="text-align:left" | EUR million unless otherwise mentioned
! class="col-s" style="text-align:right" | FY25
Line 1,394 ⟶ 1,278:
! class="col-m" style="text-align:right" | Other metrics
|-
| style="text-align:left" | Current'''Technical Accident Year Undiscounted Technicalresult''' Margin(pre-tax)
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Undiscounted technical margin (current accident year)
| style="text-align:right" | 2,778
| style="text-align:right" | +707
| style="text-align:right" | —
|-
| style="text-align:left" | Gross Earnedearned Premiumspremiums
| style="text-align:right" | 57,656
| style="text-align:right" | +6%
| style="text-align:right" | —
|-
| style="text-align:left" | CurrentUndiscounted Accidentcombined Yearratio Undiscounted(current Combinedaccident Ratioyear)
| style="text-align:right" | 95.2%
| style="text-align:right" | -1.0pt
Line 1,414 ⟶ 1,303:
| style="text-align:right" | —
|-
| style="text-align:left" | CurrentDiscounting Accident(current Yearaccident Discountingyear)
| style="text-align:right" | 2,009
| style="text-align:right" | +115
| style="text-align:right" | —
|-
| style="text-align:left" | Discounting Ratio (in Combined Ratio points)ratio
| style="text-align:right" | -3.5%
| style="text-align:right" | +0.0pt
| style="text-align:right" | —
|-
| style="text-align:left" | CurrentNet Accidentclaims Yearreserves Net(current Claimsaccident reservesyear)
| style="text-align:right" | 19.0bn
| style="text-align:right" | —
Line 1,434 ⟶ 1,323:
| style="text-align:right" | —
|-
| style="text-align:left" | CurrentDiscount Accidentrate Year(current Discountaccident rateyear)
| style="text-align:right" | 2.8%
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Prior Yearsyears' Reservereserve Developmentdevelopment (PYD)
| style="text-align:right" | 622
| style="text-align:right" | -341
Line 1,449 ⟶ 1,338:
| style="text-align:right" | —
|-
| style="text-align:left" | Investment'''Financial Incomeresult''' (pre-tax)
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Investment income
| style="text-align:right" | 3,988
| style="text-align:right" | +435
| style="text-align:right" | —
|-
| style="text-align:left" | FY25 Average Assetsassets (FY25)
| style="text-align:right" | 115bn
| style="text-align:right" | —
Line 1,464 ⟶ 1,358:
| style="text-align:right" | —
|-
| style="text-align:left" | FY25 Reinvestment yield (on fixed income assets)
| style="text-align:right" | 4.3%
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Insurance Financefinance Expensesexpenses
| style="text-align:right" | -1,358
| style="text-align:right" | -235
| style="text-align:right" | —
|-
| style="text-align:left" | FY24 Reserves at locked-in rate (FY24)
| style="text-align:right" | 71bn
| style="text-align:right" | —
Line 1,484 ⟶ 1,378:
| style="text-align:right" | —
|-
| style="text-align:left" | '''Underlying Earningsearnings before tax'''
| style="text-align:right" | 8,040
| style="text-align:right" | +681
Line 1,494 ⟶ 1,388:
| style="text-align:right" | —
|-
| style="text-align:left" | Affiliates, Minorityminority interests & Otherother
| style="text-align:right" | -108
| style="text-align:right" | -10
| style="text-align:right" | —
|-
| style="text-align:left" | '''Underlying Earningsearnings'''
| style="text-align:right" | 5,872
| style="text-align:right" | +501
| style="text-align:right" | +9% growth vs. FY24 at constant FX of +9%
|}
</div>
Line 1,508 ⟶ 1,402:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ FY25Discount rate sensitivity toof CurrentFY25 Accidentcurrent Yearaccident discountyear ratenet reserve changesdiscounting <sup>p. 42</sup>
! style="text-align:left" | Change in discount rateShift
! class="col-s" style="text-align:right" | Impact (EUR billion)
|-
| style="text-align:left" | +25bps
Line 1,522 ⟶ 1,416:
<div style="overflow-x:auto">
{| class="wikitable"
|+ 2026e Insurance Financefinance Expensesexpenses expected for 2026 (pre-tax) and sensitivity <sup>p. 42</sup>
! style="text-align:left" | Item
! class="col-s" style="text-align:right" | Value
|-
| style="text-align:left" | 2026e Insurance Finance Expenses (pre-tax)expenses
| class="col-s" style="text-align:right" | ~ -1.4bn
|}
</div>
 
<div style="overflow-x:auto">
{| class="wikitable"
|+ Sensitivity of 2026e expenses to changes in 2025 current accident year discount <sup>p. 42</sup>
! style="text-align:left" | Shift
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" | Sensitivity to 2025 current AY Discount +25bps
| class="col-s" style="text-align:right" | ~ -50m
|-
| style="text-align:left" | Sensitivity to 2025 current AY Discount -25bps
| class="col-s" style="text-align:right" | ~ +50m
|}
Line 1,541 ⟶ 1,443:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ L&H margin analysis, FY25 vs FY24 at constant FX <sup>p. 43</sup>
! style="text-align:left" | EUR million unless otherwise mentioned
! class="col-sm" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change vs FY24
! class="col-m" style="text-align:right" | Other metrics
|-
| style="text-align:left" | '''Short-term Technical Margin'''
| style="text-align:right" | 479
| style="text-align:right" | +60
| style="text-align:right" | Including recapture of Laya
|-
| style="text-align:left" | Gross Earnedearned Premiumspremiums
| style="text-align:right" | 17,416
| style="text-align:right" | +10%
| style="text-align:right" | —
|-
| style="text-align:left" | All Yearyear Combinedcombined Ratioratio
| style="text-align:right" | 97.2%
| style="text-align:right" | -0.1pt1pts
| style="text-align:right" | includes recapture of Laya
|-
| style="text-align:left" | '''Long-term Technical Margin'''
| style="text-align:right" | 2,804
| style="text-align:right" | +156
Line 1,577 ⟶ 1,479:
| style="text-align:right" | —
|-
| style="text-align:left" | '''Investment Income (non-VFA only)'''
| style="text-align:right" | 2,484
| style="text-align:right" | -1
| style="text-align:right" | —
|-
| style="text-align:left" | FY25 Average Assetsassets
| style="text-align:right" | 98bn
| style="text-align:right" | —
Line 1,592 ⟶ 1,494:
| style="text-align:right" | —
|-
| style="text-align:left" | FY25 Reinvestment yield (on fixed income assets)
| style="text-align:right" | 3.8% on fixed income assets
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | '''Insurance Finance Expenses (non-VFA only)'''
| style="text-align:right" | -1,538
| style="text-align:right" | -9
| style="text-align:right" | —
|-
| style="text-align:left" | FY24 Reserves at locked-in rate
| style="text-align:right" | 62bn (FY24)
| style="text-align:right" | —
| style="text-align:right" | —
Line 1,612 ⟶ 1,514:
| style="text-align:right" | —
|-
| style="text-align:left" | '''Underlying Earnings before tax'''
| style="text-align:right" | 4,229
| style="text-align:right" | +205
Line 1,622 ⟶ 1,524:
| style="text-align:right" | —
|-
| style="text-align:left" | Affiliates, Minorityminority interests & Otherother
| style="text-align:right" | 72
| style="text-align:right" | -51
| style="text-align:right" | —
|-
| style="text-align:left" | '''Underlying Earnings'''
| style="text-align:right" | 3,501
| style="text-align:right" | +219
| style="text-align:right" | +7% growth vs. FY24 at constant FX of +7%
|}
</div>
Line 1,637 ⟶ 1,539:
{| class="wikitable fintable"
|+ Life & Health FY25 CSM Key Sensitivities <sup>p. 43</sup>
! style="text-align:left" | ScenarioSensitivity
! class="col-s" style="text-align:right" | EUR billion
|-
Line 1,668 ⟶ 1,570:
|}
</div>
* '''L&H margin analysis''' includes scope impact <sup>p. 43</sup>.
 
* '''Table of contents''' <sup>p. 44</sup>navigation:
** 1. '''Debt and Invested Assets''' <sup>p. 31</sup>
** 2. '''Additional P&C disclosures''' <sup>p. 36</sup>
** 3. '''Additional IFRS17 disclosures''' <sup>p. 41</sup>
** 4. '''Sustainability''' <sup>p. 44</sup>
 
Line 1,679 ⟶ 1,582:
<div style="overflow-x:auto">
{| class="wikitable"
|+ SustainabilityAXA targetsfor andProgress 2025Index resultsperformance dashboard <sup>p. 45</sup>
! style="text-align:left" | CategoryRole
! class="col-m" style="text-align:right" | Metric
! class="col-m" style="text-align:right" | Target
! class="col-m" style="text-align:right" | 2025 Result
|-
| style="text-align:left" | ClimateAs transitiona financingGlobal Investor
| class="col-m" style="text-align:right" | Climate transition financing
| class="col-m" style="text-align:right" | EUR 5bn per year
| class="col-m" style="text-align:right" | EUR 6.4bn
|-
| style="text-align:left" | Community resilience financing
| class="col-m" style="text-align:right" | Community resilience financing
| class="col-m" style="text-align:right" | >EUR 500m per year
| class="col-m" style="text-align:right" | EUR 1.4bn
|-
| style="text-align:left" | P&CAs GWPa toGlobal support transition underwriting (cumulative 2024-2026)Insurer
| class="col-m" style="text-align:right" | EURTransition 6bnunderwriting
| class="col-m" style="text-align:right" | EUR 6bn in P&C GWP (cumulative 2024-2026)
| class="col-m" style="text-align:right" | EUR 4.6bn
|-
| style="text-align:left" | Climate adaptation solutions & services (cumulative 2024-2026)
| class="col-m" style="text-align:right" | >20,000Climate adaptation solutions
| class="col-m" style="text-align:right" | 19>20,698000 solutions & services (cumulative 2024-20252026)
| class="col-m" style="text-align:right" | 19,698 (cumulative 2024-2025)
|-
| style="text-align:left" | Inclusive insurance customers
| class="col-m" style="text-align:right" | >20mInclusive by 2026insurance
| class="col-m" style="text-align:right" | >20m customers by 2026
| class="col-m" style="text-align:right" | 20.6m
|-
| style="text-align:left" | AXAAs Groupa employees trained on climate adaptationCompany
| class="col-m" style="text-align:right" | >80,000Climate by 2026training
| class="col-m" style="text-align:right" | >80,000 AXA Group employees trained on climate adaptation by 2026
| class="col-m" style="text-align:right" | 46,420
|-
| style="text-align:left" | Absolute carbon emissions reduction
| class="col-m" style="text-align:right" | Net-50%Zero by 2030contribution
| class="col-m" style="text-align:right" | -50% by 2030 in absolute carbon emissions and offset of residual emissions
| class="col-m" style="text-align:right" | -64% reduction against 2019
|-
| style="text-align:left" | Employee volunteering engagement
| class="col-m" style="text-align:right" | Employee volunteering
| class="col-m" style="text-align:right" | 50% of AXA Group employees engaged in volunteering activities by 2026
| class="col-m" style="text-align:right" | 56%
|}
</div>
* '''Climate adaptation solutions & services''' target (cumulative 2024-2026): >20,000 (target revised in 2025 from >9,000); 2025 Result: 19,698 cumulative 2024-2025 <sup>p. 45</sup>
* '''Absolute carbon emissions reduction''' target: -50% by 2030 (against 2019 baseline; scope: energy Scopes 1 and 2, car fleet and business travel) and offset of residual emissions; 2025 Result: -64% reduction against 2019 <sup>p. 45</sup>
 
=== Sustainability Performance & Ratings ===
Line 1,725 ⟶ 1,635:
{| class="wikitable"
|+ ESG ratings and scores <sup>p. 46</sup>
! style="text-align:left" | ProviderRating Agency
! class="col-m" style="text-align:right" | 2025 Score / RatingPercentile
|-
| style="text-align:left" | S&P Global
| class="col-m" style="text-align:right" | 97th percentile¹ in Dow Jones Best-in-Class Europe & World indices
|-
| style="text-align:left" | MSCI
Line 1,741 ⟶ 1,651:
|-
| style="text-align:left" | FTSE Russell
| class="col-m" style="text-align:right" | 4.3/5 in FTSE4Good Index Series
|}
</div>
* "The CSA ranking is a key performance indicator for AXA Group, used to calculate the grant of Long-Term Incentives (more preciselyspecifically AXA Restricted Shares)., with Resultsresults as of February 6th, 2026."
* '''S&P Global''' 2025 percentile was 97th (footnote 1) in Dow Jones Best-in-Class Europe & World indices <sup>p. 46</sup>.
* '''FTSE Russell''' 2025 score was 4.3/5 in FTSE4Good Index Series <sup>p. 46</sup>.
 
=== Scope ===
 
* '''France''': scope includes insurance activities, banking activities, and holding <sup>p. 47</sup>.
* '''Europe''': scope includes Switzerland (insurance activities), Germany (insurance activities and holding), Belgium and LuxemburgLuxembourg (insurance activities and holding), United Kingdom and Ireland (insurance activities and holding), Spain (insurance activities and holdings), Italy (insurance activities), Prima (insurance activities), and AXA Life Europe (insurance activities) <sup>p. 47</sup>.
* '''AXA XL''': scope includes insurance and reinsurance activities and holding <sup>p. 47</sup>.
* '''Asia, Africa & EME-LATAM''': scope includes: <sup>p. 47</sup>
** '''Asia''': Japan (insurance activities and holding), Hong Kong (insurance activities), Thailand P&C, China P&C, South Korea, and Asia Holdings which are(all fully consolidated, and); China L&S, Thailand L&S, the Philippines L&S and P&C, Indonesia L&S, and India (Life activities disposed on March 11, 2024 and holding) businesses which are (consolidated under the equity method, and contributecontributing only to NBV, PVEP, the underlying earnings, and net income) <sup>p. 47</sup>.
** '''Africa''': Morocco (insurance activities and holding) and, Nigeria (insurance activities and holding), and Egypt (insurance activities and holding) which are(all fully consolidated) <sup>p. 47</sup>.
** '''EME-LATAM''': Mexico (insurance activities), Colombia (insurance activities), Brazil (insurance activities and holding), and Türkiye (insurance activities and holding) which are(all fully consolidated as well as); Russia (Reso) (insurance activities) which (consolidated under the equity method, and contributescontributing only to the net income) <sup>p. 47</sup>.
** '''AXA Mediterranean Holdings''' <sup>p. 47</sup>.
* '''Transversal & Other''': scope includes AXA Assistance, AXA Liabilities Managers, AXA, and other Central Holdings <sup>p. 47</sup>.
* '''AXA Investment Managers''' (until July 1, 2025): scope includes AXA Investment Managers, Select (previously referred to as Architas), and Capza which are(all fully consolidated), and Asian joint ventures which are (consolidated under the equity method) <sup>p. 47</sup>.
* '''Accounting standards''' note: Unlessunless otherwise specified herein, all comparative figures going back to 2023 are under the IFRS17/9 accounting standards that became effective on January 1, 2023; figures for financial periods prior to 2023 have not been restated under IFRS17/9 and are presented under IFRS4 <sup>p. 47</sup>.
 
=== Glossary ===
 
* '''Capital-light G/A products''': encompass all products with no guarantees, with guarantees at maturity only or with guarantees equal to or lower than 0% <sup>p. 48</sup>
* '''Contractual Service Margin''' (CSM)''': a component of the carrying amount of asset or liability for a group of insurance contracts representing the unearned profit to be recognized as services are provided to policyholders <sup>p. 48</sup>
* '''CSM release''': a portion of CSM stock net of reinsurance at the end of the defined period flowing through profit and loss representing the estimated profit earned by the insurer for providing insurance services during the reporting period <sup>p. 48</sup>
* '''Economic variance''': corresponds to the variance of the year-end CSM arising from changes in market conditions, net of the underlying return on in-force <sup>p. 48</sup>
* '''Financial result''': consists of investment income on assets backing BBA and PAA contracts as well as assets backing shareholder's equity, net of the insurance finance expenses (IFE) defined as the unwind of the present value of future cash flow <sup>p. 48</sup>
* '''Gross Written Premiums''' and Other Revenues (GWP & Other Revenues)''': represent the insurance premiums collected during the period (including risk premiums, premiums from pure investment contracts with no discretionary participating features, fees and revenues, net of commissions paid on assumed reinsurance business);. Other Revenues represent premiums and fees collected on activities other than insurance (i.e. banking, services, and asset management activities) <sup>p. 48</sup>
* '''New Business Value''' (NBV)''': the value of newly issued contracts during the current year,. It consistingconsists of the sum of (i) the new business contractual service margin, (ii) the present value of the future profits of short-term newly issued contracts during the period, carried by Life entities, considering expected renewals, (iii) the present value of the future profits of pure investment contracts accounted for under IFRS 9, net of (iv) the cost of reinsurance, (v) taxes and (vi) minority interests <sup>p. 48</sup>
* '''New Business CSM'''Contractual Service Margin (NB CSM)''': a component of the carrying amount of the asset or liability for newly issued insurance contracts during the period, representing the unearned profit to be recognized as insurance contract services are provided <sup>p. 48</sup>
* '''New Business Value margin''' (NBV margin)''': ratio of (i) NBV, representing the value of newly issued contracts during the current year, to (ii) PVEP <sup>p. 48</sup>
* '''Operating variance''': the variation of the year-end CSM versus the expected at opening due to (i) the differences between realized and expected operational assumptions, (ii) changes in assumptions such as mortality, longevity, lapses and expenses, and (iii) impact of model changes;. operatingOperating variance is net of reinsurance <sup>p. 48</sup>
* '''Present value of expected premiums''' (PVEP)''': the new business volume, equal to the present value at the time of issue of the total premiums expected to be received over the policy term;. PVEP is discounted at the reference interest rate and PVEP is Group share <sup>p. 48</sup>
* '''Technical experience''': consists of the impacts on the underlying earnings of (i) the difference between the expected and incurred cash-flows of the defined period, (ii) the risk adjustment release, (iii) the changes in onerous contracts, and (iv) the other long-term elements which are mainly composed of non-attributable expenses <sup>p. 48</sup>
* '''Underlying return on in-force''': represents the release of Time Value of Options & Guarantees (TVOG) plus the unwind of CSM at the reference rate plus the underlying financial over-performance <sup>p. 48</sup>
Line 1,778 ⟶ 1,690:
=== February 26, 2026 Thank you Full Year 2025 earnings ===
 
* '''Presentation conclusion''':AXA Full Year 2025 Earnings''' presentation concludedclosing slide, ondated February 26, 2026 <sup>p. 49</sup>
 
== Abbreviations ==
 
* '''AA''': Senior bond rating (Standard & Poor's)Secured
* '''AAA''': Senior bond rating (Standard & Poor's)Secured
* '''ABS''': Asset-Backed Securities
* '''AEP''': Aggregate Exceedance Probability
Line 1,789 ⟶ 1,701:
* '''APAC''': Asia-Pacific
* '''AXA IM''': AXA Investment Managers
* '''BBA''': Benefits-Based Annuities
* '''AXA XL''': AXA XL (AXA's large property and casualty commercial lines and specialty risk division)
* '''AY''': Accident Year
* '''BBA''': Beneficial interest in a Block of business of Annuities
* '''CDP''': Carbon Disclosure Project
* '''CLO''': Collateralized Loan Obligation
Line 1,797 ⟶ 1,707:
* '''CSA''': Corporate Sustainability Assessment
* '''CSM''': Contractual Service Margin
* '''CY''': CalendarCurrent Year
* '''DPS''': Dividend Per Share
* '''EME''': EmergingEurope, MarketsMiddle East, and Africa
* '''EOF''': Eligible Own Funds
* '''EPS''': Earnings Per Share
* '''ESG''': Environmental, Social, and Governance
* '''EU''': European Union
* '''EUR''': Euro
* '''FX''': Foreign Exchange
* '''GAAP''': Generally Accepted Accounting Principles
* '''GEP''': Gross Earned Premiums
* '''GF EUR''': Grandfathered Euro
* '''GF GBP''': Grandfathered Great British Pound
* '''GWP''': Gross Written Premiums
* '''HKD''': Hong Kong Dollar
Line 1,821 ⟶ 1,728:
* '''LTV''': Loan-to-Value
* '''MSCI''': Morgan Stanley Capital International
* '''MX''': Mexico
* '''NA''': North America
* '''NB CSM''': New Business Contractual Service Margin
* '''NBV''': New Business Value
* '''NHG''': Nationale Hypotheek Garantie (National Mortgage Guarantee)
* '''NPS''': Net Promoter Score
* '''OCI''': Other Comprehensive Income
Line 1,832 ⟶ 1,738:
* '''PVEP''': Present Value of Expected Profits
* '''PYD''': Prior Years' Reserve Development
* '''ROERCG''': ReturnRealized OnCapital EquityGains
* '''ROE''': Return on Equity
* '''SCR''': Solvency Capital Requirement
* '''SHE''': Shareholders' Equity
* '''SME''': Small and Medium-sized Enterprises
* '''TVOG''': Time Value of Options &and Guarantees
* '''UEPS''': Underlying Earnings Per Share
* '''UK''': United Kingdom